Key Takeaways STERIS' Healthcare segment delivered 9% revenue growth in fiscal Q2, led by consumables and services.STERIS' AST segment grew 10% year over year in fiscal Q2, driven by higher service revenues and demand.STERIS closed fiscal Q2 with $319M in cash, lower long-term debt, and no short-term debt reported then.STERIS plc (STE) is well-poised to gain in the upcoming quarters thanks to its Healthcare segment, which continues to see strong market adoption of its comprehensive offerings, including infe ...